Harding Dan, Cameron Lee, Monga Aastha, Winter Sara
Aneurin Bevan University Health Board, Caerleon, UK.
School of Allied Health Professions, Keele University, Keele, UK.
Musculoskeletal Care. 2024 Jun;22(2):e1892. doi: 10.1002/msc.1892.
Evidence is lacking for the efficacy of shockwave therapy (SWT) in the treatment of greater trochanteric pain syndrome (GTPS).
To investigate the efficacy of SWT on pain and function in the management of GTPS.
A systematic search of electronic databases and grey literature was conducted up to May 2023. Studies utilising SWT on adults for GTPS, providing measures of pain and/or function at baseline and at follow-up were considered for inclusion. Meta-analysis was undertaken using converted pain and functional outcomes. Studies were assessed for quality and risk of bias, and assigned a level of evidence as per the Grading of Recommendations, Assessment, Development and Evaluations criteria.
Twelve articles (n = 1121 subjects) were included, including five randomised controlled trials (RCTs) and seven non-RCTs. No statistical differences were observed for pain over time f(1,5) = 1.349 (p = 0.298) or between SWT and control f(1,5) = 1.782 (p = 0.238). No significant differences in functional outcomes in short- (H = 2.591, p = 0.181) and medium-term follow-up (H = 0.189, p = 0.664) were identified between SWT and control. Moderate magnitude treatment effects for pain (Hedges-G [HG] 0.71) favouring SWT groups over control was identified, decreasing to low for function (HG 0.20). Further pain and functional treatment effects were identified at higher magnitudes across follow-up time-points in SWT groups compared to control.
Moderate-quality evidence demonstrated no statistically significant improvements in pain and function post-SWT compared to control. Low-quality evidence established clinical improvements throughout all included studies favouring SWT over control. Consequently, owing to relatively low incidence of side effects, SWT should be considered a viable option for the management of GTPS. Issues with both clinical and statistical heterogeneity of studies and during meta-analysis require consideration, and more robust RCTs are recommended if the efficacy of SWT for the management of GTPS is to be comprehensively determined.
缺乏冲击波疗法(SWT)治疗大转子疼痛综合征(GTPS)疗效的证据。
探讨SWT对GTPS患者疼痛和功能的治疗效果。
截至2023年5月,对电子数据库和灰色文献进行系统检索。纳入使用SWT治疗成人GTPS且在基线和随访时提供疼痛和/或功能测量指标的研究。采用转换后的疼痛和功能结局进行荟萃分析。对研究进行质量和偏倚风险评估,并根据推荐分级、评估、制定与评价标准确定证据水平。
纳入12篇文章(n = 1121名受试者),包括5项随机对照试验(RCT)和7项非RCT。随时间推移疼痛方面未观察到统计学差异(f(1,5) = 1.349,p = 0.298),SWT组与对照组之间也无差异(f(1,5) = 1.782,p = 0.238)。在短期(H = 2.591,p = 0.181)和中期随访(H = 0.189,p = 0.664)中,SWT组与对照组在功能结局方面未发现显著差异。确定了对疼痛的中度治疗效果(Hedges-G [HG] 0.71),SWT组优于对照组,功能方面降至低度(HG 0.20)。与对照组相比,在SWT组随访时间点上,在更高程度上发现了进一步的疼痛和功能治疗效果。
中等质量证据表明,与对照组相比,SWT后疼痛和功能无统计学显著改善。低质量证据表明,在所有纳入研究中,临床改善情况支持SWT优于对照组。因此,由于副作用发生率相对较低,SWT应被视为治疗GTPS的可行选择。研究的临床和统计异质性以及荟萃分析过程中的问题需要考虑,如果要全面确定SWT治疗GTPS的疗效,建议进行更有力的RCT。